Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Daily weigh-ins create too much noise from water fluctuations and can cause unnecessary stress
[76] [77] In a 72-week, phase IIIb open-label head-to-head trial of adults with obesity without diabetes, tirzepatide at the maximum tolerated dose produced greater mean weight loss than semaglutide and larger reductions in waist circumference, while gastrointestinal adverse events were the most common with both drugs
Tirzepatide is typically prescribed for people with a body mass index (BMI) above a certain level or those who have other health concerns related to obesity
Originally approved for type 2 diabetes, the diabetes drug Mounjaro not only treats diabetes but also aids in weight control, leading to its off-label use for obesity
NexLife plans are offered as a subscription and may be canceled at any time
Its your treatment, made for you
US$ 22.27
US$ 21.33
US$ 28.94
US$ 26.05
US$ 25.92
US$ 21.18
